soul trial oral semaglutide cardiovascular outcomes 2024 nejm results found to lower risk of heart failure events in people with type 2 diabetes The Effects of Semaglutide on

In the 2021 STEP-1 trial (1,961 adults with obesity or overweight), participants receiving semaglutide plus lifestyle intervention experienced a 14.9% mean weight loss after 68 weeks, while those on placebo lost only 2.4%

Nearly all GLP-1 agonists approved in the US for diabetes also induce some weight loss

It can speed healing and regeneration in your body without the need for anesthesia, lengthy downtime, or a surgical wound

Many traditional weight loss medications come with a laundry list of potential side effects, including increased heart rate, insomnia, dependency risks, or hormonal disruptions

Dont waitour $149 lab work and consultation special wont last long